Plasma miR-21 and miR-31 as Predictive Biomarkers for Evaluation of Therapeutic Efficacy in Metastatic Colorectal Cancer

1. Aoki H., Nosho K., Igarashi H., Ito M., Mitsuhashi K., Naito T., Yamamoto E., Tanuma T., Nomura M., Maguchi H, Shinohara T, Suzuki H., Yamamoto H., Shinomura Y. MicroRNA-31 expression in colorectal serrated pathway progression // World Journal of Gastroenterology, 2013; 20(34); 12346-1234910.3748/wjg.v20.i34.12346416182225232271Search in Google Scholar

2. Chung S., Dwabe S., Elshimali Y., Sukhija H., Aroh C., Vadgama JV. Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis- Antibody Array and Intracellular Signaling Array // PLoS ONE, 2015; 10(8): e0134948.doi:10.1371/ journal.pone.013494810.1371/journal.pone.0134948453095326258407Search in Google Scholar

3. Coppede F., Lopomo A., Spisni R., Migliore L. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer // World Journal of Gastroenterology, 2014; 20(4): 943-956Search in Google Scholar

4. Edwards M.S., Chadda S. D., Zhao Z., Barber B. L. Sykes D. P. A systematic review of treatment guidelines for metastatic colorectal cancer // Color. Dis., 2012; 14: 31-47Search in Google Scholar

5. Gonzalez-Pons M., Cruz-Correa M. Colorectal Cancer Biomarkers: Where Are We Now? // BioMed Research International, 2015: 1-1410.1155/2015/149014446172626106599Search in Google Scholar

6. Greene F. L., Sobin L. H. The Staging of Cancer: A Retrospective and Prospective Appraisal // CA Cancer J Clin, 2008; DOI: 10.3322/CA.2008.000110.3322/CA.2008.000118460593Search in Google Scholar

7. Kirstein M. M., Lange A., Prenzler A., Manns M. P., Kubicka S., Vogel A. Targeted Therapies in Metastatic Colorectal Cancer: A Systematic Review and Assessment of Currently Available Data // The Oncologist, 2014; 19:1156-1168Search in Google Scholar

8. Lei S.L., Zhao H., Yao H. L., Chen Y., Lei Z. D., Liu K. J., Yang Q. Regulatory roles of microRNA708 and microRNA31 in proliferation, apoptosis and invasion of colorectal cancer cells // Oncology Letters, 2014; 8: 1768-1774Search in Google Scholar

9. Mazeh H., Mizrahi I., Ilyayev N., Halle D., Brücher LDM B., Bilchik A., Protic M., Daumer M., Stojadinovic A., Avital I., Nissan A. The Diagnostic and Prognostic Role of microRNA in Colorectal Cancer - a Comprehensive review // Journal of Cancer; 2013; 4(3): 281-295. doi: 10.7150/jca.583610.7150/jca.5836358484123459799Search in Google Scholar

10. Peng Y., Zhai Z., Li Z., Wang L., Gu J. Role of blood tumor markers in predicting metastasis and local recurrence after curative resection of colon cancer // Int J Clin Exp Med, 2015; 8(1):982-990Search in Google Scholar

11. Reimers M. S., Zeestraten E. C.M., Kuppen P. J.K., Liefers G. J., van de Velde C.J.H. Biomarkers in precision therapy in colorectal cancer // Gastroenterology Report 2013; 166-183, doi:10.1093/gastro/got02210.1093/gastro/got022393799724759962Search in Google Scholar

12. Ross J. S., Torres-Mora J., Wagle N., Jennings T. A., Jones D. M. Biomarker-Based Prediction of Response to Therapy for Colorectal Cancer // American Society for Clinical Pathology, 2010; 134:478-490Search in Google Scholar

13. Schee K., Boye K., Weum Abrahamsen T., Fodstad O., Flatmark K. Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer // 2012; Bio Med Central Cancer 12:50510.1186/1471-2407-12-505351962223121918Search in Google Scholar

14. Sun D., Yu F., Ma Y., et al. MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1) // Journal of Biological Chemistry. 2013; 288(13):9508-9518Search in Google Scholar

15. Wang J., Huang S., Zhao M., Yang M., Zhong J., Gu Y., Peng H., Che Y., Huang C. Identification of a Circulating MicroRNA Signature for Colorectal Cancer Detection // PLOS ONE, 2014; 9(4) e87451: 1-910.1371/journal.pone.0087451397785424709885Search in Google Scholar

16. Xu X. M., Qian J. C., Deng Z. L., Cai Z., Tang T., Wang P., Zhang K. H., Cai J.I.P. Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer // Oncology Letters, 2012; 4: 339-345Search in Google Scholar